Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 10-20 of  210 results for ""THERAPEUTIC use of protease inhibitors""

Your Filters

Subject : antiviral agents
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

High Detection Rate of HIV Drug Resistance Mutations among Patients Who Fail Combined Antiretroviral Therapy in Manaus, Brazil.

Subjects: *THERAPEUTIC use of protease inhibitors; *DIAGNOSIS of HIV infections; *GENETIC mutationBRAZIL

  • Source: BioMed Research International. 6/9/2021, p1-9. 9p.

Record details

Read Online Read More Add to Saved list
×
Periodical

Activity of THC, CBD, and CBN on Human ACE2 and SARS-CoV1/2 Main Protease to Understand Antiviral Defense Mechanism.

Subjects: THERAPEUTIC use of protease inhibitors; CANNABIDIOL; IN vitro studies

  • Source: Planta Medica; Oct2022, Vol. 88 Issue 12, p1047-1059, 13p

Record details

Read More Add to Saved list
×
Periodical

Glecaprevir and Pibrentasvir Tablets (Mavyret).

Subjects: *THERAPEUTIC use of protease inhibitors; *ANTIVIRAL agents; *PROTEASE inhibitors

  • Source: Internal Medicine Alert. 9/30/2017, Vol. 39 Issue 18, p141-142. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 Treatment: The Race Against Time.

Subjects: *THERAPEUTIC use of protease inhibitors; *ANTIVIRAL agents; *CHLOROQUINE

  • Source: Electronic Journal of General Medicine. 2020, Vol. 17 Issue 6, p1-3. 3p.

Record details

Read More Add to Saved list
×
Periodical

The Lowdown on Drugs to Treat COVID-19.

Subjects: *THERAPEUTIC use of monoclonal antibodies; *THERAPEUTIC use of protease inhibitors; *ANTIVIRAL agents

  • Source: Emergency Medicine News. 5/13/2020, Vol. 42 Issue 5A, p5-6. 2p.

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy

Subjects: *THERAPEUTIC use of protease inhibitors; *ANTIVIRAL agents; *COMBINATION drug therapy

  • Source: HIV Medicine. Nov2010, Vol. 11 Issue 10, p666-669. 4p. 1 Chart.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

US Real-World Effectiveness Study of Nirmatrelvir/Ritonavir in Preventing Hospitalization of High-Risk COVID-19 Patients.

Subjects: *THERAPEUTIC use of protease inhibitors; *COMBINATION drug therapy; *MEDICAL care useUNITED States

  • Source: Current Therapeutic Research. 2024, Vol. 101, pN.PAG-N.PAG. 1p.

Record details

Read More Add to Saved list
×
Academic Journal

Rutin: A Potential Antiviral for Repurposing as a SARS-CoV-2 Main Protease (Mpro) Inhibitor.

Subjects: SARS-CoV-2; ANTIVIRAL agents; VIRUS inhibitors

  • Source: Natural Product Communications; Apr2021, Vol. 16 Issue 4, p1-12, 12p

Record details

Read More Add to Saved list
×
Academic Journal

Potential therapeutic targets and promising drugs for combating SARS-CoV-2.

Subjects: SARS-CoV-2; DRUG design; PATHOLOGY

  • Source: British Journal of Pharmacology; Jul2020, Vol. 177 Issue 14, p3147-3161, 15p, 2 Diagrams

Record details

Read Online Read More Add to Saved list
×
Academic Journal

COVID-19 in Children: Clinical Approach and Management.

Subjects: THERAPEUTIC use of protease inhibitors; SARS diagnosis; SARS prevention

  • Source: Indian Journal of Pediatrics; Jun2020, Vol. 87 Issue 6, p433-442, 10p

Record details

Read More Add to Saved list
×
  • 10-20 of  210 results for ""THERAPEUTIC use of protease inhibitors""